MOHW postponed NHI coverage suspension for efficacy unproven drugs.

Published: 2001-10-30 07:00:00

Updated: 2001-10-30 07:00:00

The MOHW announced on Oct. 24 that the NHI payment rejection plan for the drugs that were not completed with their efficacy equivalent tests starting from Nov. 1 this year would put off until May next year.

Earlier on May 7 the MOHW changed the NHI medication payment system including the upper limits of the reimbursement and the NHI payment rejection for the drugs that were not completed wit...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.